Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

KALA holding history

KALA BIO, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALA overviewAll 13F holders of KALAFull Q2 2026 holdings

Shares (Q2 2026)
28
Value
$48
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KALA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628$48<0.1%−2,913−99.0%ReducedHolders
Q1 20262,941$509<0.1%+2,334+384.5%AddedHolders
Q4 2025607$338<0.1%−926−60.4%ReducedHolders
Q3 20251,533$2.35K<0.1%+561+57.7%AddedHolders
Q2 2025972$4.63K<0.1%00.0%UnchangedHolders
Q1 2025972$5.57K<0.1%00.0%UnchangedHolders
Q4 2024972$6.75K<0.1%−23−2.3%ReducedHolders
Q3 2024995$5.67K<0.1%−20−2.0%ReducedHolders
Q2 20241,015$7.20K<0.1%−346−25.4%ReducedHolders
Q1 20241,361$10.8K<0.1%−260−16.0%ReducedHolders
Q4 20231,621$11.4K<0.1%−32−1.9%ReducedHolders
Q3 20231,653$14.7K<0.1%00.0%UnchangedHolders
Q2 20231,653$24.1K<0.1%+95+6.1%AddedHolders
Q1 20231,558$23.4K<0.1%−536−25.6%ReducedHolders
Q4 20222,094$79.9K<0.1%+28+1.4%AddedConverted for a 1-for-50 splitHolders
Q3 2022103,292$23.0K<0.1%−20,273−16.4%ReducedHolders
Q2 2022123,565$37.0K<0.1%−29,146−19.1%ReducedHolders
Q1 2022152,711$210.0K<0.1%−61,273−28.6%ReducedHolders
Q4 2021213,984$260.0K<0.1%−92,397−30.2%ReducedHolders
Q3 2021306,381$802.0K<0.1%+83,819+37.7%AddedHolders
Q2 2021222,562$1.18M<0.1%+115,613+108.1%AddedHolders
Q1 2021106,949$721.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.